Literature DB >> 21091648

Functional antagonism of β-adrenoceptor subtypes in the catecholamine-induced automatism in rat myocardium.

D C Boer1, J W M Bassani, R A Bassani.   

Abstract

BACKGROUND AND
PURPOSE: Myocardial automatism and arrhythmias may ensue during strong sympathetic stimulation. We sought to investigate the relevant types of adrenoceptor, as well as the role of phosphodiesterase (PDE) activity, in the production of catecholaminergic automatism in atrial and ventricular rat myocardium. EXPERIMENTAL APPROACH: The effects of adrenoceptor agonists on the rate of spontaneous contractions (automatic response) and the amplitude of electrically evoked contractions (inotropic response) were determined in left atria and ventricular myocytes isolated from Wistar rats. KEY
RESULTS: Catecholaminergic automatism was Ca(2+) -dependent, as it required a functional sarcoplasmic reticulum to be exhibited. Although both α- and β-adrenoceptor activation caused inotropic stimulation, only β(1) -adrenoceptors seemed to mediate the induction of spontaneous activity. Catecholaminergic automatism was enhanced and suppressed by β(2) -adrenoceptor blockade and stimulation respectively. Inhibition of either PDE3 or PDE4 (by milrinone and rolipram, respectively) potentiated the automatic response of myocytes to catecholamines. However, only rolipram abolished the attenuation of automatism produced by β(2) -adrenoceptor stimulation. CONCLUSIONS AND IMPLICATIONS: α- and β(2) -adrenoceptors do not seem to be involved in the mediation of catecholaminergic stimulation of spontaneous activity in atrial and ventricular myocardium. However, a functional antagonism of β(1) - and β(2) -adrenoceptor activation was identified, the former mediating catecholaminergic myocardial automatism and the latter attenuating this effect. Results suggest that hydrolysis of cAMP by PDE4 is involved in the protective effect mediated by β(2) -adrenoceptor stimulation.
© 2011 The Authors. British Journal of Pharmacology © 2011 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21091648      PMCID: PMC3058164          DOI: 10.1111/j.1476-5381.2010.01121.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  43 in total

Review 1.  Adrenergic and muscarinic receptors in the human heart.

Authors:  O E Brodde; M C Michel
Journal:  Pharmacol Rev       Date:  1999-12       Impact factor: 25.468

2.  Opposing effects of beta(1)- and beta(2)-adrenergic receptors on cardiac myocyte apoptosis : role of a pertussis toxin-sensitive G protein.

Authors:  C Communal; K Singh; D B Sawyer; W S Colucci
Journal:  Circulation       Date:  1999-11-30       Impact factor: 29.690

3.  Sinoatrial nodal cell ryanodine receptor and Na(+)-Ca(2+) exchanger: molecular partners in pacemaker regulation.

Authors:  K Y Bogdanov; T M Vinogradova; E G Lakatta
Journal:  Circ Res       Date:  2001-06-22       Impact factor: 17.367

4.  Rest-dependence of twitch amplitude and sarcoplasmic reticulum calcium content in the developing rat myocardium.

Authors:  S A Ferraz; J W Bassani; R A Bassani
Journal:  J Mol Cell Cardiol       Date:  2001-04       Impact factor: 5.000

Review 5.  Myocardial phosphodiesterases and regulation of cardiac contractility in health and cardiac disease.

Authors:  Oleg E Osadchii
Journal:  Cardiovasc Drugs Ther       Date:  2007-03-21       Impact factor: 3.727

6.  beta(1) and beta(2)-adrenergic receptor subtype effects in German shepherd dogs with inherited lethal ventricular arrhythmias.

Authors:  E A Sosunov; R Z Gainullin; N S Moise; S F Steinberg; P Danilo; M R Rosen
Journal:  Cardiovasc Res       Date:  2000-11       Impact factor: 10.787

7.  Protein kinase A phosphorylation of the ryanodine receptor does not affect calcium sparks in mouse ventricular myocytes.

Authors:  Yanxia Li; Evangelia G Kranias; Gregory A Mignery; Donald M Bers
Journal:  Circ Res       Date:  2002-02-22       Impact factor: 17.367

Review 8.  Autonomic nerve activity and atrial fibrillation.

Authors:  Peng-Sheng Chen; Alex Y Tan
Journal:  Heart Rhythm       Date:  2006-12-15       Impact factor: 6.343

Review 9.  beta(2)-Adrenoceptors and ventricular fibrillation.

Authors:  R A Altschuld; G E Billman
Journal:  Pharmacol Ther       Date:  2000-10       Impact factor: 12.310

10.  Phosphodiesterase-4 blunts inotropism and arrhythmias but not sinoatrial tachycardia of (-)-adrenaline mediated through mouse cardiac beta(1)-adrenoceptors.

Authors:  A Galindo-Tovar; A J Kaumann
Journal:  Br J Pharmacol       Date:  2007-12-17       Impact factor: 8.739

View more
  2 in total

1.  Adrenoceptor sub-type involvement in Ca2+ current stimulation by noradrenaline in human and rabbit atrial myocytes.

Authors:  Priyanka Saxena; Rachel C Myles; Godfrey L Smith; Antony J Workman
Journal:  Pflugers Arch       Date:  2022-09-22       Impact factor: 4.458

2.  High Thyrotropin Is Critical for Cardiac Electrical Remodeling and Arrhythmia Vulnerability in Hypothyroidism.

Authors:  Julieta Fernandez-Ruocco; Monica Gallego; Ainhoa Rodriguez-de-Yurre; Julian Zayas-Arrabal; Leyre Echeazarra; Amaia Alquiza; Victor Fernández-López; Juan M Rodriguez-Robledo; Oscar Brito; Ygor Schleier; Marisa Sepulveda; Natalia F Oshiyama; Martin Vila-Petroff; Rosana A Bassani; Emiliano H Medei; Oscar Casis
Journal:  Thyroid       Date:  2019-06-13       Impact factor: 6.568

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.